Back to Journals » Drug Design, Development and Therapy » Volume 10
Original Research
A novel imidazopyridine derivative, X22, attenuates sepsis-induced lung and liver injury by inhibiting the inflammatory response in vitro and in vivo
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,113 | Dovepress* | 9,258+ | 1,640 | 10,898 | |
PubMed Central* | 855 | 245 | 1,100 | ||
Totals | 10,113 | 1,885 | 11,998 | ||
*Since 24 June 2016 +Since July 2016 |
View citations on PubMed Central and Google Scholar